Long-term use: Clinical trials only ran 12 weeks, so long-term safety data (6+ months continuous use) comes from anecdotal reports
This means that although most people meet their B12 needs, a significant minority may not have optimal levels, particularly in higher-risk groups
B12 injections have been all the rage recently, so lets talk about them today
Vitamin B12 deficiency can cause pernicious anemia, fatigue, and nerve damage
Reconstituting KLOW All four peptides are premixed in a KLOW vial any draw calculation therefore uses the vials full 80 mg at the fixed 5:1:1:1 ratio
Blood cell production typically begins improving within 35 days, haemoglobin rises over 12 months, whilst neurological recovery may take several months